Ted William Karkus, a major owner of ProPhase Labs and ProPhase Labs's CEO & CHAIRMAN and a director of the company, recently acquired 164,679 shares of the company. The buys took place at prices ranging from $1.65 to $5.45 per share, on May 15, 2018. Karkus now owns 2,649,528 shares of the company. Karkus operates out of Doylestown, PA. Some additional info was provided as follows:
These employee stock options vested in annual installments of 50,000 and 50,000 shares on December 19, 2014 and 2015, respectively.
There employee stock options vested in an annual installment of 150,000 shares on April 26, 2018.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs Just Received a Notice of Effectiveness - July 5, 2018
Registration statement under Securities Act of 1933 - June 25, 2018